Axsome Therapeutics, Inc.
AXSM
Revenue
87.17M
▲12.17M▲16.22%
3 Months ChangeAssets
548.23M
▲2.50M▲0.4577%
3 Months ChangeLiabilities
445.37M
▲43.68M▲10.87%
3 Months ChangeFree Cash Flow
-53.57M
▼-47.67M▼-809.11%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0000950170-24-110957
2024-09-04
Form 8-K
ID: 0000950170-24-103098
2024-08-21
Form 8-K
ID: 0000950170-24-099389
2024-08-05
Form 10-Q
ID: 0000950170-24-090828
2024-08-05
Form 8-K
ID: 0000950170-24-090311
2024-06-11
Form 8-K
ID: 0000950170-24-071960
2024-06-05
Form 8-K
ID: 0000950170-24-069077
2024-05-06
Form 10-Q
ID: 0000950170-24-053697
2024-05-06
Form 8-K
ID: 0000950170-24-053197
2024-04-01
Form 8-K
ID: 0000950170-24-038894